| 摘要 |
<p>The invention is concerned with novel heterocyclyl compounds of formula (I) wherein A, X, Y1, Y2, Y3, R3, R4, R5, R6, R7, R8, R9, R10, m, n and p are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and can be used as medicaments.</p> |
| 申请人 |
F. HOFFMANN-LA ROCHE AG |
发明人 |
AEBI, JOHANNES;BINGGELI, ALFRED;GREEN, LUKE;HARTMANN, GUIDO;MAERKI, HANS, P.;MATTEI, PATRIZIO;RICKLIN, FABIENNE;ROCHE, OLIVIER |
